Account
Inquiry
QSC tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for research applications. This synthetic peptide mimics the action of endogenous incretins to enhance insulin secretion and suppress glucagon levels.
The QSC tirzepatide formulation consists of a 39-amino acid peptide backbone with specific modifications including two non-natural residues (Aib at positions 2 and 13) and a C20 fatty diacid side chain at Lys20, contributing to its extended research utility.
Our QSC tirzepatide is available in lyophilized powder form with purity exceeding 99%, making it suitable for various research applications. The product undergoes rigorous quality control testing including HPLC and mass spectrometry analysis to ensure batch-to-batch consistency.
For laboratory use only. This product is not intended for human consumption and should only be handled by qualified researchers in controlled laboratory settings. Proper safety protocols should always be followed when working with peptide compounds.
